CN111592935A - Method for enriching antibacterial components of cinnamomum camphora essential oil - Google Patents
Method for enriching antibacterial components of cinnamomum camphora essential oil Download PDFInfo
- Publication number
- CN111592935A CN111592935A CN202010337233.6A CN202010337233A CN111592935A CN 111592935 A CN111592935 A CN 111592935A CN 202010337233 A CN202010337233 A CN 202010337233A CN 111592935 A CN111592935 A CN 111592935A
- Authority
- CN
- China
- Prior art keywords
- essential oil
- molecular distillation
- enriching
- temperature
- components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 74
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 title claims abstract description 62
- 241000723346 Cinnamomum camphora Species 0.000 title claims abstract description 62
- 238000000034 method Methods 0.000 title claims abstract description 35
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 19
- 238000000199 molecular distillation Methods 0.000 claims abstract description 50
- 229960000846 camphor Drugs 0.000 claims abstract description 35
- 229930008380 camphor Natural products 0.000 claims abstract description 35
- 230000003385 bacteriostatic effect Effects 0.000 claims abstract description 31
- 238000001704 evaporation Methods 0.000 claims abstract description 23
- 238000009833 condensation Methods 0.000 claims abstract description 22
- 230000005494 condensation Effects 0.000 claims abstract description 22
- 230000008020 evaporation Effects 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 238000007790 scraping Methods 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 17
- 239000010779 crude oil Substances 0.000 description 12
- KRCZYMFUWVJCLI-UHFFFAOYSA-N Dihydrocarveol Chemical compound CC1CCC(C(C)=C)CC1O KRCZYMFUWVJCLI-UHFFFAOYSA-N 0.000 description 8
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- NNRLDGQZIVUQTE-UHFFFAOYSA-N gamma-Terpineol Chemical compound CC(C)=C1CCC(C)(O)CC1 NNRLDGQZIVUQTE-UHFFFAOYSA-N 0.000 description 8
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 8
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 244000063299 Bacillus subtilis Species 0.000 description 6
- 235000014469 Bacillus subtilis Nutrition 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 241000228245 Aspergillus niger Species 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- JPTOCTSNXXKSSN-UHFFFAOYSA-N methylheptenone Chemical compound CCCC=CC(=O)CC JPTOCTSNXXKSSN-UHFFFAOYSA-N 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 4
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 4
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 4
- 229940088601 alpha-terpineol Drugs 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 229930007024 dihydrocarveol Natural products 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 229930007744 linalool Natural products 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000003822 preparative gas chromatography Methods 0.000 description 2
- 238000013138 pruning Methods 0.000 description 2
- 238000010223 real-time analysis Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 241000337007 Oceania Species 0.000 description 1
- 206010057040 Temperature intolerance Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 230000008543 heat sensitivity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000012855 volatile organic compound Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/02—Recovery or refining of essential oils from raw materials
- C11B9/027—Recovery of volatiles by distillation or stripping
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/24—Lauraceae [Laurel family], e.g. laurel, avocado, sassafras, cinnamon or camphor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Agronomy & Crop Science (AREA)
- Biotechnology (AREA)
- Environmental Sciences (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a method for enriching bacteriostatic components in camphor essential oil, which comprises the following steps of extracting the camphor essential oil: performing first-stage molecular distillation by using Cinnamomum camphora essential oil as raw material and setting molecular distillation evaporation temperature at 60 + -2 deg.C, system pressure at 100 + -10 Pa, primary condensation temperature at 20 + -1 deg.C, and secondary condensation temperature at-20 + -1 deg.C; with the resulting first light fraction (1D)L) Setting evaporation temperature at 40 + -2 deg.C, system pressure at 150 + -10 Pa, primary condensation temperature at 15 + -1 deg.C, and secondary condensation temperature at-20 + -1 deg.C as raw materials, and performing second-stage molecular distillation; obtaining a second-grade light fraction (2D)L). The method of the invention can effectively protect essential oil components from being damaged.
Description
Technical Field
The invention relates to a process for enriching antibacterial components of camphor essential oil.
Background
Cinnamomum camphora (Cinnamomum camphora), originating in southern china, vietnam, japan, etc., is a large evergreen tree widely distributed in the east asia, oceania, and pacific islands. The cinnamomum camphora is an important economic tree species in China and one of the tree species with the highest planting rate in urban greening, the planting area reaches more than 5 million hectares, and the cinnamomum camphora increases year by year. According to the pruning rate of 5% every year, branches and leaves generated by pruning only one medium-sized city can reach 3 ten thousand tons, and the waste branches and leaves can be used for extracting the camphor essential oil, so that the environmental pollution is effectively reduced. The essential oil extracted from the cinnamomum has various antibacterial activities, and can be widely used in industries of essence, spice, medicine and the like. However, in general, compared with the traditional bacteriostatic agent, the natural essential oil has weaker bacteriostatic activity, and because the plant essential oil is a complex mixture consisting of a series of volatile organic compounds, finding the target component with bacteriostatic effect is very difficult, so that if a proper separation technology can be found to enrich the components in the camphor essential oil, the specific bacteriostatic active ingredients in the essential oil can be expected to be determined, so that the bacteriostatic activity of the camphor essential oil can be improved, and the additional value of the essential oil product can be further increased.
In the method for concentrating the effective components in the essential oil, a chemical method is a traditional method for purifying the essential oil, but the prepared essential oil is generally low in purity, complex in process flow and easy to have solvent residues. The rectification method and the preparative gas chromatography have high separation degree, but have obvious defects, the rectification method usually needs higher temperature and is easy to damage components in the essential oil, and the preparative gas chromatography has high equipment requirement, has extremely small amount of the essential oil which can be separated, is mainly used for qualitative analysis of the essential oil components and cannot be used in large scale.
Currently, some new methods are attracting attention, wherein the molecular distillation is performed under the conditions of high vacuum degree and low evaporation temperature, the distance between the evaporator and the condenser is small, the residence time of the molecules in the heated area of the evaporator is short, so that the heat-sensitive substances can be effectively prevented from being damaged, no solvent is required to be used, and the problems of solvent residue and the like do not exist. The research shows that the molecular distillation can effectively enrich antioxidant active ingredients in the essential oil, concentrate essence flavor substances and remove impurities, so that the quality of the essential oil is improved, but the research on enriching antibacterial ingredients in the cinnamomum camphora essential oil by molecular distillation is not reported yet.
Disclosure of Invention
The invention aims to solve the technical problem of providing a method for enriching the antibacterial components of the camphor essential oil, which has the advantages of simple process, high antibacterial activity, safety, high efficiency, greenness and environmental protection.
In order to solve the technical problems, the invention provides a method for enriching bacteriostatic components of camphor essential oil, which comprises the following steps of:
first), first stage molecular distillation:
performing first-stage molecular distillation by using Cinnamomum camphora essential oil as raw material and setting molecular distillation evaporation temperature at 60 + -2 deg.C, system pressure at 100 + -10 Pa, primary condensation temperature at 20 + -1 deg.C, and secondary condensation temperature at-20 + -1 deg.C;
the following three fractions were obtained, respectively: first heavy fraction (1R)H) First middle distillate (1D)M) And a first light fraction (1D)L)；
Second), second stage molecular distillation:
with a first light fraction (1D)L) Setting evaporation temperature at 40 + -2 deg.C, system pressure at 150 + -10 Pa, primary condensation temperature at 15 + -1 deg.C, and secondary condensation temperature at-20 + -1 deg.C as raw materials, and performing second-stage molecular distillation;
the following three fractions were obtained, respectively: second heavy fraction (2R)H) Second middle distillate (2D)M) And a second light fraction (2D)L)。
Second grade light fraction (2D)L) The bacteriostatic effect is optimal.
The improvement of the method for enriching the antibacterial component in the camphor essential oil comprises the following steps: in the step one), the retention time of the camphor essential oil in the system (device) is 8-12 s.
The method for enriching the antibacterial component in the camphor essential oil is further improved as follows: in the first step), the feeding flow rate is 2.5mL/min, and the film scraping rotation speed is 100 rpm.
The method for enriching the antibacterial component in the camphor essential oil is further improved as follows: in the second step, the first-stage light fraction (1D)L) The residence time in the system (device) is 8-12 s.
The method for enriching the antibacterial component in the camphor essential oil is further improved as follows: in the second step), the feeding flow rate is 2.5mL/min, and the film scraping rotation speed is 100 rpm.
In the invention, the extraction of the cinnamomum camphora essential oil is carried out in a conventional way: cleaning the branches and leaves of Cinnamomum camphora, drying in the shade at room temperature, drying, cutting into pieces, grinding into powder with liquid nitrogen, extracting by steam distillation, removing water with anhydrous sodium sulfate to obtain Cinnamomum camphora essential oil (crude oil), sealing, storing in brown glass bottle at 4 deg.C, and storing.
Molecular distillation: the raw material to be treated is placed in a molecular distillation device, and the evaporation intensity is adjusted by changing the evaporation temperature and the system pressure. Under the appropriate evaporation intensity, the temperature of the primary condenser is adjusted; the secondary condenser temperature was set at (-20 + -1) deg.C to ensure that all components reaching the secondary condenser were condensed. Three fractions can be obtained by each stage of molecular distillation: heavy fraction (R)H) Middle distillate (D)M) And a light fraction (D)L). By adopting the method, the target components in the essential oil can be enriched in the corresponding fractions.
The first stage of molecular distillation takes camphor essential oil as raw material; in the second stage of molecular distillation, the fraction with high enrichment degree and enhanced bacteriostatic activity obtained in the first stage is used as a raw material. The invention adopts two-stage molecular distillation to further improve the concentration degree of the target component and obtain better enrichment effect and bacteriostatic activity.
In the invention, a gas chromatography-mass spectrometer (GC-MS) is adopted to carry out real-time analysis on chemical compositions of the cinnamomum camphora crude oil and each fraction obtained by molecular distillation, and the molecular distillation condition is adjusted through the flow direction of a target component.
The selection of the molecular distillation experimental conditions mainly considers the mass recovery rate of each fraction and the concentration ratio of main components of the essential oil. The recovery rate of each fraction is calculated by the formula:
the concentration ratio of the main components in each fraction is calculated according to the formula:
the concentration ratio of the target component is the ratio of the mass percentage of the target component in each fraction to the mass percentage of the corresponding component in the cinnamomum camphora crude oil. A concentration ratio greater than 1 indicates that the target component in the fraction is concentrated, i.e. effectively enriched by molecular distillation. The larger the concentration ratio, the better the enrichment effect.
The minimum inhibitory concentrations of the cinnamomum camphora crude oil and each fraction to two gram-positive bacteria (staphylococcus aureus and bacillus subtilis), two gram-negative bacteria (escherichia coli and pseudomonas aeruginosa) and two fungi (aspergillus niger and candida albicans) are respectively determined by a microdilution method. To more intuitively understand the gain or loss of bacteriostatic activity of each fraction after the two-stage molecular distillation, the bacteriostatic rating was defined in terms of the MIC value. The higher the MIC value is, the weaker the bacteriostatic effect of the essential oil is, and therefore the lower the bacteriostatic grade is. When the MIC value is 20 mug/mL, the bacteriostatic effect is a high-activity level; when the MIC value is gradually increased to 100 mu g/mL and 500 mu g/mL respectively, the bacteriostasis level is decreased to medium and high activity; when the MIC value is increased to 1000 mug/mL or more, the bacteriostatic effect is weak activity level and no activity level respectively.
The method for enriching the antibacterial components of the camphor essential oil is to enrich the antibacterial active components in the camphor essential oil by adopting two-stage molecular distillation; the method specifically comprises the steps of taking the cinnamomum camphora essential oil as a raw material, separating and concentrating components in the essential oil by utilizing two-stage molecular distillation, enriching components with bacteriostatic active ingredients in the essential oil, and improving the bacteriostatic activity of the cinnamomum camphora essential oil.
In the invention, the feeding flow rate is set to be 2.5mL/min, the rotating speed of the film scraping is set to be 100rpm, the retention time from the upper end to the lower end of the evaporator is about 10s after the essential oil enters the evaporation system, and a uniform film can be formed on the surface of the evaporator, thereby ensuring that the inflowing material can be fully evaporated.
Under the optimal operation conditions of the molecular distillation of the first stage, the recovery rate of each fraction is as follows: first heavy fraction (1R)H) 13.79% of first middle distillate (1D)M) 71.93%, first light fraction (1D)L)10.17％。
Through two-stage molecular distillation, the target components in heavy fractions are alpha-terpineol and gamma-terpineol; the target components in the middle distillate are linalool and dihydrocarveol; the target components in the light fraction are methylheptenone and 1, 8-cineole.
After the two-stage molecular distillation of the invention, the first light fraction (1D)L) The concentration ratio of the target components of methyl heptenone and 1, 8-cineole can be respectively up to 5.72 and 5.16, and the concentration ratio of the second-level light fraction (2D)L) The concentration ratios of the two target components were further improved, and the final concentration ratios were 9.61 and 10.63, respectively.
The antibacterial activity of the camphor essential oil is two-stage molecular distillation, and then the two-stage light fraction (2D)L) Compared with crude oil, the inhibitor has obviously improved inhibiting effect on staphylococcus aureus and bacillus subtilis, and certain enhancement on the inhibition of fungi.
The method for enriching the antibacterial components of the camphor essential oil has the following characteristics:
1) the proper evaporation intensity can be obtained by regulating and controlling the evaporation temperature and the system pressure;
2) adjusting the first-stage condensation temperature to enable the volatile essential oil target components to be condensed by two-stage condensers respectively, so that the volatile essential oil target components are enriched in corresponding fractions;
3) the second stage of molecular distillation can further obtain better enrichment effect of target components;
4) the operation process is low in temperature and oxygen-isolated, and the components with heat sensitivity and easy oxidation are protected;
5) the real-time analysis of GC-MS is combined, so that the molecular distillation condition can be better adjusted;
6) the camphor essential oil has obvious bacteriostatic component enrichment effect and obviously improved bacteriostatic activity.
In conclusion, the method adopts two-stage molecular distillation, has the advantages of low system pressure, mild evaporation temperature, short component heating time, adjustable primary condensation temperature, environmental protection and the like, and effectively protects essential oil components from being damaged compared with the traditional essential oil component concentration method.
Drawings
The following describes embodiments of the present invention in further detail with reference to the accompanying drawings.
FIG. 1 is a schematic diagram of two-stage molecular distillation for enriching the components of Cinnamomum camphora essential oil;
FIG. 2 is a schematic view of a molecular distillation apparatus.
Detailed Description
The invention will be further described with reference to specific examples, but the scope of the invention is not limited thereto:
the following examples were carried out in a conventional molecular distillation apparatus as shown in FIG. 2, which consists of four sections of evaporation system, vacuum system, heating and condensing, feeding and discharging.
After the essential oil material enters the evaporator from the feeding device at the top of the evaporator, an even film is formed on the surface of the evaporator under the rotating wiping action of the scraper, so that the evaporation area of the material is increased, and the material can be uniformly heated. Under proper evaporation intensity, most of the non-volatile components (dark background color in fig. 1 a) in the essential oil material with film-shaped evaporator surface can not be vaporized, and will flow out along the evaporator wall to become first-order heavy fraction (1R)H) (ii) a After the volatile component has evaporated, it is due to the molecular mean free path (
And
) Above the distillation distance, it can escape from the oil film layer and reach the condenser, and after the components (light background color number in FIG. 1 a) captured by the primary condenser flow out, a primary middle distillate (1D) is formedM) (ii) a While a small portion of the components (no background color numbers in fig. 1 a) with mean free path much larger than the distillation distance will "bounce" to the secondary condenser and become the first light fraction (1D) due to incomplete condensation on the first condenserL). Then the first-grade light fraction (1D) with high enrichment degree of target components and obviously enhanced antibacterial activity is usedL) A second stage of molecular distillation was carried out on the batch to obtain further three fractions: second heavy fraction (2R)H) Second middle distillate (2D)M) Second grade light ends (2D)L)。
Example 1, a method for enriching bacteriostatic components of camphor essential oil sequentially comprises the following steps:
1) and extracting the camphor essential oil:
cleaning the camphor branches and leaves, cutting the camphor branches and leaves into pieces after moisture on the surface of dried leaves at room temperature, grinding the cut camphor branches and leaves into powder by using liquid nitrogen, extracting essential oil by adopting a Clevenger-type device through steam distillation, wherein the material-liquid ratio of the camphor branches and leaves to steam is 1g/4mL, extracting for 1 hour, standing and layering the obtained reflux liquid, taking upper-layer oily matter, removing water by using anhydrous sodium sulfate to obtain camphor essential oil (crude oil), and storing the camphor essential oil (crude oil) in a brown glass bottle in a sealed manner at a low temperature of 4 ℃;
the obtained camphor essential oil comprises the following target components in percentage by weight:
39.63% of alpha-terpineol, 10.30% of gamma-terpineol, 26.32% of linalool, 6.17% of dihydrocarveol, 1.50% of methyl heptenone and 3.45% of 1, 8-cineole.
2) And the first stage of molecular distillation:
100mL of cinnamomum camphora crude oil is measured and placed in a molecular distillation feeding device, the evaporation temperature is set to be 60 ℃, the system pressure is set to be 100Pa, the feeding flow rate is set to be 2.5mL/min, the film scraping rotation speed is 100rpm, the primary condensation temperature is set to be 20 ℃, the secondary condensation temperature is set to be minus 20 ℃, and the first-stage molecular distillation is carried out. At this time, the residence time of the cinnamomum camphora crude oil in the evaporator is about 10 s.
The resulting first heavy fraction (1R)H) First middle distillate (1D)M) First-order light fraction (1D)L) The recovery rates are respectively as follows: 13.79%, 71.93%, 10.17%.
Performing GC-MS analysis on the three fractions, wherein the target components and the content thereof in each fraction are as follows:
first heavy fraction (1R)H) α -terpineol 47.38%, gamma-terpineol 12.40%, concentration ratio 1.20.
First middle distillate (1D)M): linalool 32.65%, dihydrocarveol 6.64%, concentration ratio of 1.24 and 1.08 respectively.
First-order light fraction (1D)L): 8.57 percent of methyl heptenone and 17.81 percent of 1, 8-eucalyptol, and the concentration ratios are 5.72 and 5.16 respectively.
3) Minimum Inhibitory Concentration (MIC) of camphor crude oil and fractions obtained by the first-stage molecular distillation:
measuring MIC values of crude oil of cinnamomum camphora and fractions obtained by molecular distillation in the first stage on gram-positive bacteria (staphylococcus aureus, bacillus subtilis), gram-negative bacteria (escherichia coli, pseudomonas aeruginosa) and fungi (aspergillus niger and candida albicans) by a microdilution method, preparing a 1% DMSO essential oil sample solution, adding 50 mu L of an essential oil sample and 50 mu L of a broth culture medium (Mueller Hinton broth) into each hole of a first row of a 96-well plate at the beginning, diluting each row according to a ratio of 1:1, taking gentamicin as a positive control, taking DMSO as a negative control, and adding 50 mu L of the culture medium with a concentration of about 1.5 × 10 into each hole8CFU/mL test bacterial suspension. After the 96-well plate is cultured for 24h at 37 ℃, the turbidity of the bacterial suspension at 610nm is detected, the final MIC value is the lowest concentration of the essential oil sample without turbidity, and the test is repeated three times.
The culture medium in the antifungal activity test is a special Yeast Mold culture medium (Yeast and Mold Broth), the positive control is amphotericin B, and after culture for 72 hours at 28 ℃, the change of the turbidity of the fungal spore liquid is observed.
The results obtained are described in table 1 below.
TABLE 1 bacteriostatic results of crude cinnamomum camphora oil and fractions obtained by first stage molecular distillation
The MIC values of the cinnamomum camphora essential oil (cinnamomum camphora crude oil) to staphylococcus aureus and bacillus subtilis are both 625 mug/mL, and the cinnamomum camphora essential oil has weak activity bacteriostasis; the MIC value to the escherichia coli is 625 mug/mL, the weak activity bacteriostasis is realized, and the MIC value to the pseudomonas aeruginosa is 1250 mug/mL, the bacteriostasis activity is avoided; MIC values for Aspergillus niger and Candida albicans were 39. mu.g/mL and 312.5. mu.g/mL, respectively, with moderate and above levels of inhibition.
First-order light fraction (1D)L) The antibacterial effect of the composition is highest, wherein the MIC values of staphylococcus aureus and bacillus subtilis are both 78 mug/mL, and the antibacterial level is medium-high activity; the MIC value of the recombinant plasmid to escherichia coli is 312.5 mug/mL, and the bacteriostatic level is medium activity; the MIC value to pseudomonas aeruginosa is 1250 mug/mL, and the bacteriostatic activity is not existed; the MIC value of the aspergillus niger is 19.5 mug/mL, and the bacteriostasis level is high activity; the MIC value of the candida albicans is 156 mug/mL, and the bacteriostasis level is medium activity.
4) And second-stage molecular distillation:
taking the first-stage light fraction (1D) obtained in the step 2)L)10mL, placing the mixture into a molecular distillation feeding device, setting the evaporation temperature to be 40 ℃, the system pressure to be 150Pa, the feeding flow rate to be 2.5mL/min, the rotating speed of a knifing to be 100rpm, the primary condensation temperature to be 15 ℃, and the secondary condensation temperature to be-20 ℃, and carrying out the second stage of molecular distillation. The resulting second heavy fraction (2R)H) Second middle distillate (2D)M) Second grade light ends (2D)L) The recovery rates are respectively as follows: 29.75%, 45.77%, 19.45%. At this time, the first light fraction (1D)L) The residence time in the evaporator was about 10 s.
Performing GC-MS analysis on the three fractions, wherein the target components and the content thereof in each fraction are as follows:
second heavy fraction (2R)H) α -terpineol 26.21% and gamma-terpineol 6.55%, the concentration ratio is 1.88 and1.89。
second middle distillate (2D)M): 47.20% of linalool and 8.39% of dihydrocarveol, and the concentration ratios are 1.25 and 1.19 respectively.
Second grade light fraction (2D)L): 14.42 percent of methyl heptenone and 36.62 percent of 1, 8-cineole, and the concentration ratios are 1.68 and 2.06 respectively.
5) And the Minimum Inhibitory Concentration (MIC) of each fraction obtained by the second stage molecular distillation:
the measurement method was referred to the above step 3).
The results obtained were:
second grade light fraction (2D)L) The inhibition effect on gram-positive bacteria (staphylococcus aureus and bacillus subtilis) is further enhanced, wherein the MIC value of the staphylococcus aureus is 19.5 mu g/mL, and the bacteriostasis level is high activity; inhibitory activity against gram-negative bacteria (E.coli and P.aeruginosa) and fungi (A.niger and C.albicans) and the first light fraction (1D)L) Are substantially the same.
Comparative example 1-1, the evaporation temperature in step 2) of example 1 was changed to 65 ℃ and the system pressure was changed to 5 Pa; the rest is equivalent to 1) to 3) of embodiment 1.
Comparative examples 1-2, the first-order condensation temperature of step 2) of example 1 was changed to 10 ℃; the rest is equivalent to 1) to 3) of embodiment 1.
Comparative example 2-1, the feed flow rate of step 2) of example 1 was changed to 1mL/min, and the wiped film rotation speed was changed to 80rpm, thereby correspondingly changing the residence time of the material in the evaporator (about 14 s); the rest is equivalent to 1) to 3) of embodiment 1.
Comparative example 2-2, the feed flow rate of step 2) of example 1 was changed to 3.5mL/min and the wiped film speed was changed to 150rpm, thereby correspondingly changing the residence time of the material in the evaporator (about 7 s); the rest is equivalent to 1) to 3) of embodiment 1.
The resulting first light fraction (1D)L) The bacteriostatic effect of (a) is as described in table 2 below.
Table 2, comparative example 1-1 to comparative example 2-2 first-order light fraction (1D)L) The bacteriostatic effect of
Comparative example 3, the evaporation temperature of step 4) of example 1 was changed to 50 ℃, the system pressure was changed to 100Pa, and the primary condensation temperature was changed to 10 ℃; the rest is equivalent to embodiment 1.
The results obtained were: second grade light fraction (2D)L) The bacteriostatic effect of the light fraction (1D) is basically the same as that of the first-stage light fractionL)。
Comparative example 4, the evaporating temperature in step 4) of example 1 was changed to 35 ℃, the system pressure was changed to 120Pa, and the primary condensing temperature was changed to 20 ℃; the rest is equivalent to embodiment 1.
The results obtained were: second grade light fraction (2D)L) The bacteriostatic effect of the light fraction (1D) is basically the same as that of the first-stage light fractionL)。
Finally, it is also noted that the above-mentioned lists merely illustrate a few specific embodiments of the invention. It is obvious that the invention is not limited to the above embodiments, but that many variations are possible. All modifications which can be derived or suggested by a person skilled in the art from the disclosure of the present invention are to be considered within the scope of the invention.
Claims (5)
1. The method for enriching antibacterial components in camphor essential oil comprises the extraction of camphor essential oil, and is characterized in that: the method comprises the following steps:
first), first stage molecular distillation:
performing first-stage molecular distillation by using Cinnamomum camphora essential oil as raw material and setting molecular distillation evaporation temperature at 60 + -2 deg.C, system pressure at 100 + -10 Pa, primary condensation temperature at 20 + -1 deg.C, and secondary condensation temperature at-20 + -1 deg.C;
the following three fractions were obtained, respectively: first heavy fraction (1R)H) First middle distillate (1D)M) And a first light fraction (1D)L)；
Second), second stage molecular distillation:
with a first light fraction (1D)L) Setting evaporation temperature at 40 + -2 deg.C, system pressure at 150 + -10 Pa, primary condensation temperature at 15 + -1 deg.C, and secondary condensation temperature at-20 + -1 deg.C as raw materials, and performing evaporation at the temperature of 40 + -2 deg.C, and performing secondary condensation at the temperature of 20 + -1 deg.CPerforming second-stage molecular distillation;
the following three fractions were obtained, respectively: second heavy fraction (2R)H) Second middle distillate (2D)M) And a second light fraction (2D)L)。
2. The method for enriching bacteriostatic components in camphor essential oil as claimed in claim 1, which is characterized by comprising the following steps:
in the first step), the residence time of the camphor essential oil in the system is 8-12 s.
3. The method for enriching bacteriostatic components in cinnamomum camphora essential oil according to claim 1 or 2, which is characterized in that:
in the first step), the feeding flow rate is 2.5mL/min, and the film scraping rotation speed is 100 rpm.
4. The method for enriching bacteriostatic components in camphor essential oil according to any one of claims 1 to 3, which is characterized by comprising the following steps:
in the second step, the first-stage light fraction (1D)L) The residence time in the system is 8-12 s.
5. The method for enriching bacteriostatic components in camphor essential oil as claimed in claim 4, which is characterized by comprising the following steps:
in the second step), the feeding flow rate is 2.5mL/min, and the film scraping rotation speed is 100 rpm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010337233.6A CN111592935A (en) | 2020-04-26 | 2020-04-26 | Method for enriching antibacterial components of cinnamomum camphora essential oil |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010337233.6A CN111592935A (en) | 2020-04-26 | 2020-04-26 | Method for enriching antibacterial components of cinnamomum camphora essential oil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111592935A true CN111592935A (en) | 2020-08-28 |
Family
ID=72180199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010337233.6A Pending CN111592935A (en) | 2020-04-26 | 2020-04-26 | Method for enriching antibacterial components of cinnamomum camphora essential oil |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111592935A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105861158A (en) * | 2016-06-07 | 2016-08-17 | 湖北中烟工业有限责任公司 | Preparation method of high-purity lemongrass essential oil |
| CN106318644A (en) * | 2016-11-02 | 2017-01-11 | 赣南师范大学 | Preparation method of navel orange essential oil molecule distillation component |
| CN109463402A (en) * | 2018-11-30 | 2019-03-15 | 福建农林大学 | A kind of preparation method and application of cinnamomum camphora essential oil quorum-quenching agent |
| CN110150333A (en) * | 2019-05-16 | 2019-08-23 | 井冈山大学 | A kind of oil camphor tree leaf essential oil bacteriostasis method |
-
2020
- 2020-04-26 CN CN202010337233.6A patent/CN111592935A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105861158A (en) * | 2016-06-07 | 2016-08-17 | 湖北中烟工业有限责任公司 | Preparation method of high-purity lemongrass essential oil |
| CN106318644A (en) * | 2016-11-02 | 2017-01-11 | 赣南师范大学 | Preparation method of navel orange essential oil molecule distillation component |
| CN109463402A (en) * | 2018-11-30 | 2019-03-15 | 福建农林大学 | A kind of preparation method and application of cinnamomum camphora essential oil quorum-quenching agent |
| CN110150333A (en) * | 2019-05-16 | 2019-08-23 | 井冈山大学 | A kind of oil camphor tree leaf essential oil bacteriostasis method |
Non-Patent Citations (1)
| Title |
|---|
| 王芳等: "结合GC-MS的分子蒸馏富集柚皮精油抗氧化成分的研究", 《中国粮油学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schmidt | Production of essential oils | |
| CN102041174B (en) | Preparation method of moss-scented tobacco flavor and application of moss-scented cigarette flavor in cigarette flavoring | |
| CN101074382A (en) | Process for extracting wood-vinegar fluid from almond | |
| Ivanov et al. | Phytochemical compounds of anise hyssop (Agastache foeniculum) and antibacterial, antioxidant, and acetylcholinesterase inhibitory properties of its essential oil | |
| Khan et al. | Molecular characterization of Penicillium expansum isolated from grapes and its management by leaf extract of Chenopodium murale | |
| CA2587756A1 (en) | Natural composition based on chilean monofloral honey extract from native vegetable species for bacterial infection control in vegetables at all | |
| Hassanzadeh et al. | Effect of Phenological Stages on Essential Oil Content, Composition and Rosmarinic Acid in Rosmarinus officinalis L. | |
| CN111592935A (en) | Method for enriching antibacterial components of cinnamomum camphora essential oil | |
| CN113773908A (en) | Preparation method and application of jasmine extract with antioxidant activity | |
| Bavaro et al. | Inhibition of aflatoxin B1 production by verbascoside and other olive polyphenols | |
| Echeverrigaray et al. | Colletotrichum species associated to ripe rot disease of grapes in the “Serra Gaucha” region of Southern Brazil | |
| Lachman et al. | Resveratrol and piceid isomers concentrations in grapevine shoots, leaves, and tendrils. | |
| KR101587717B1 (en) | Process for obtaining shikimic acid from Sicyos angultus | |
| CN111303998A (en) | Purification method of green pepper volatile oil | |
| Quyen et al. | Extraction of Kaffir Lime (Citrus hystrix DC.) essential oil by steam distillation and evaluation of chemical constituents | |
| CN110935191A (en) | Method for extracting and purifying industrial hemp wax | |
| Goneim et al. | Carrot leaves: antioxidative and nutritive values | |
| Lykholat et al. | Soluble cuticular wax composition and antimicrobial activity of the fruits of Chaenomeles species and an interspecific hybrid | |
| Łuczkiewicz et al. | From harvesting to distillation–Effect of analytical procedures on the yield and chemical composition of Rhododendron tomentosum (Ledum palustre) essential oil | |
| Do et al. | Chemical composition, antibacterial and antioxidant activities of lemongrass (Cymbopogon citratus) essential oil and its fractions obtained by vacuum distillation | |
| CN114276336A (en) | Propiconazole molecular distillation refining method | |
| Michet et al. | Chemotypes in the volatiles of wild thyme (Thymus pulegioides L.) | |
| Kahsay et al. | Antioxidant and antibacterial activities of Balanites aegyptiaca Delil from Northern Ethiopia | |
| Hashem | Response of Marjoram (Majorana Hortensis L.) Plant to foliar spraying by some antioxidants under Siwa Oasis conditions | |
| Vaverková et al. | Qualitative properties of Mentha× piperita (L.) after application of the fungicide Hattrick DP-50 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200828 |